Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: MaxCyte Inc., 3 years.
MaxCyte Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
MaxCyte Inc. June 22, 202358.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | MaxCyte Inc. | Grant or award | +30,421 | — | — |
| Aug 13, 2025 | MaxCyte Inc. | Open-market purchase | +100,000 | $1.37 | $137,000 |
| Jun 18, 2025 | MaxCyte Inc. | Grant or award | +29,210 | — | — |
| Nov 1, 2024 | MaxCyte Inc. | Option exercise | +47,689 | $0.04 | $1,908 |
| Nov 1, 2024 | MaxCyte Inc. | Open-market sale | −47,689 | $3.72 | $177,403 |
| Oct 2, 2024 | MaxCyte Inc. | Option exercise | +21,607 | $0.04 | $864 |
| Oct 2, 2024 | MaxCyte Inc. | Open-market sale | −21,607 | $3.71 | $80,162 |
| Oct 1, 2024 | MaxCyte Inc. | Option exercise | +26,082 | $0.04 | $1,043 |
| Oct 1, 2024 | MaxCyte Inc. | Open-market sale | −26,082 | $3.78 | $98,590 |
| Sep 4, 2024 | MaxCyte Inc. | Option exercise | +29,767 | $0.04 | $1,191 |
| Sep 4, 2024 | MaxCyte Inc. | Open-market sale | −29,767 | $3.97 | $118,175 |
| Sep 3, 2024 | MaxCyte Inc. | Option exercise | +17,922 | $0.04 | $717 |
| Sep 3, 2024 | MaxCyte Inc. | Open-market sale | −17,922 | $4.10 | $73,480 |
| Jun 11, 2024 | MaxCyte Inc. | Grant or award | +21,367 | — | — |
Questions about Stanley C. Erck
What boards is Stanley C. Erck on?
Stanley C. Erck sits on the board of MaxCyte Inc.
How long has Stanley C. Erck served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.